Clinical Trial Update: Prevalence, Clinical Characteristics, Progression, and Management of Neurofibromatosis Type 1 in Egypt (NF1-Egy)

View source ↗

Summary

AstraZeneca-sponsored study in Egypt is currently recruiting to investigate the prevalence, clinical characteristics, progression, and management of Neurofibrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type

Snippet

Sponsor: AstraZeneca | Conditions: Neurofibromatosis Type 1 | Status: RECRUITING